Review
Copyright ©The Author(s) 2015.
World J Hepatol. Jul 18, 2015; 7(14): 1834-1842
Published online Jul 18, 2015. doi: 10.4254/wjh.v7.i14.1834
Figure 2
Figure 2 Changes of circulating markers and immune parameters associated with good hepatocellular cancer response after radiofrequency or transarterial chemoembolization. HCC: Hepatocellular cancer; TACE: Transarterial chemoembolization; RF: Radiofrequency; AFP: Alpha-fetoprotein; DCP: Des-gamma-carboxy prothrombin; VEGF: Vascular endothelial growth factor; HIF-1a: Hypoxia inducible factor-1a; NLR: Neutrophil-to-lymphocyte ratio; sRAGE: Soluble receptor of advanced glycation end products; HSP70: Heat shock protein 70; OPN: Osteopontin; LDH: Lactate dehydrogenase.